1 Followers USX:BBI - Brickell Biotech, Inc Brickell Biotech, Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 10 Aug 2021
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 0.8694    +0.019 (+2.28%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

23 Jun 2021


Loading...
Loading...
Loading...

General

CEO: Mr. Reginald L. Hardy M.B.A., R.Ph.

IPO: 1993-03-15

Headquarters: US

Employees: 13

Homepage

Description

Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics for the treatment of skin diseases. Its pipeline consists of therapeutics for Hyperhidrosis, Cutaneous T-cell lymphoma, Psoriasis, and Other prevalent severe skin diseases. The company's pipeline products include Sofpironium Bromide, BBI-3000, and BBI-6000 among others.